Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1993 Dec;143(6):1574–1578.

Somatostatin analogue (octreotide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction.

T F Tracy Jr 1, A J Tector 1, M E Goerke 1, S Kitchen 1, D Lagunoff 1
PMCID: PMC1887254  PMID: 8256850

Abstract

Extrahepatic biliary obstruction leads to bile duct epithelial cell proliferation. Somatostatin and its analogue, octreotide, have been shown to inhibit DNA synthesis and proliferation in hepatocytes. We investigated the effect of octreotide on the biliary epithelial cell proliferative responses to biliary obstruction. Male Sprague-Dawley rats underwent common bile duct ligation and subcutaneous injection of either saline or octreotide (6 micrograms/kg) twice daily for 7 days. Morphometric analysis of hepatocytes, bile duct epithelial cells, and periportal connective tissue was performed by computerized point counting. Hepatocyte volume was preserved with octreotide treatment, which also significantly decreased bile duct proliferation and periportal extracellular matrix deposition in response to biliary obstruction compared with saline treated, duct-ligated animals. These results indicate that octreotide prevents the morphological changes that accompany extrahepatic biliary obstruction.

Full text

PDF
1574

Images in this article

1576Figure 1
on p.1576

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdel-Aziz G., Lebeau G., Rescan P. Y., Clément B., Rissel M., Deugnier Y., Campion J. P., Guillouzo A. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol. 1990 Dec;137(6):1333–1342. [PMC free article] [PubMed] [Google Scholar]
  2. Abdel-Aziz G., Rescan P. Y., Clement B., Lebeau G., Rissel M., Grimaud J. A., Campion J. P., Guillouzo A. Cellular sources of matrix proteins in experimentally induced cholestatic rat liver. J Pathol. 1991 Jun;164(2):167–174. doi: 10.1002/path.1711640211. [DOI] [PubMed] [Google Scholar]
  3. Chou C. K., Ho L. T., Ting L. P., Hu C. P., Su T. S., Chang W. C., Suen C. S., Huang M. Y., Chang C. M. Selective suppression of insulin-induced proliferation of cultured human hepatoma cells by somatostatin. J Clin Invest. 1987 Jan;79(1):175–178. doi: 10.1172/JCI112780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dixon J. M., Armstrong C. P., Duffy S. W., Davies G. C. Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut. 1983 Sep;24(9):845–852. doi: 10.1136/gut.24.9.845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Freese D. K., Snover D. C., Sharp H. L., Gross C. R., Savick S. K., Payne W. D. Chronic rejection after liver transplantation: a study of clinical, histopathological and immunological features. Hepatology. 1991 May;13(5):882–891. [PubMed] [Google Scholar]
  6. Gall J. A., Bhathal P. S. Origin and involution of hyperplastic bile ductules following total biliary obstruction. Liver. 1990 Apr;10(2):106–115. doi: 10.1111/j.1600-0676.1990.tb00443.x. [DOI] [PubMed] [Google Scholar]
  7. Gorden P., Comi R. J., Maton P. N., Go V. L. NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med. 1989 Jan 1;110(1):35–50. doi: 10.7326/0003-4819-110-1-35. [DOI] [PubMed] [Google Scholar]
  8. Kasai M., Watanabe I., Ohi R. Follow-up studies of long term survivors after hepatic portoenterostomy for "noncorrectible" biliary atresia. J Pediatr Surg. 1975 Apr;10(2):173–182. doi: 10.1016/0022-3468(75)90275-4. [DOI] [PubMed] [Google Scholar]
  9. Kokudo N., Kothary P. C., Eckhauser F. E., Nakamura T., Raper S. E. Inhibition of DNA synthesis by somatostatin in rat hepatocytes stimulated by hepatocyte growth factor or epidermal growth factor. Am J Surg. 1992 Jan;163(1):169–173. doi: 10.1016/0002-9610(92)90271-r. [DOI] [PubMed] [Google Scholar]
  10. Kountouras J., Billing B. H., Scheuer P. J. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 1984 Jun;65(3):305–311. [PMC free article] [PubMed] [Google Scholar]
  11. Lehy T., Dubrasquet M., Bonfils S. Effect of somatostatin on normal and gastric-stimulated cell proliferation in the gastric and intestinal mucosae of the rat. Digestion. 1979;19(2):99–109. doi: 10.1159/000198330. [DOI] [PubMed] [Google Scholar]
  12. McPherson G. A., Benjamin I. S., Hodgson H. J., Bowley N. B., Allison D. J., Blumgart L. H. Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg. 1984 May;71(5):371–375. doi: 10.1002/bjs.1800710522. [DOI] [PubMed] [Google Scholar]
  13. Morris J. S., Gallo G. A., Scheuer P. J., Sherlock S. Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology. 1975 Apr;68(4 Pt 1):750–754. [PubMed] [Google Scholar]
  14. Pitt H. A., Cameron J. L., Postier R. G., Gadacz T. R. Factors affecting mortality in biliary tract surgery. Am J Surg. 1981 Jan;141(1):66–72. doi: 10.1016/0002-9610(81)90014-3. [DOI] [PubMed] [Google Scholar]
  15. Pless J., Bauer W., Briner U., Doepfner W., Marbach P., Maurer R., Petcher T. J., Reubi J. C., Vonderscher J. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin. Scand J Gastroenterol Suppl. 1986;119:54–64. doi: 10.3109/00365528609087432. [DOI] [PubMed] [Google Scholar]
  16. Pruthi R. S., Farouk M., Tsai W. H., Michalopoulos G., Meyers W. C. The effect of octreotide on hepatic regeneration in rats. Surgery. 1993 Jan;113(1):84–89. [PubMed] [Google Scholar]
  17. Raper S. E., Kothary P. C., Kokudo N. Somatostatin-14 blocks the hepatotrophic effects of insulin in the rat. J Surg Res. 1991 Apr;50(4):386–390. doi: 10.1016/0022-4804(91)90207-3. [DOI] [PubMed] [Google Scholar]
  18. Serri O., Brazeau P., Kachra Z., Posner B. Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: evidence for a direct and indirect mechanism of action. Endocrinology. 1992 Apr;130(4):1816–1821. doi: 10.1210/endo.130.4.1547711. [DOI] [PubMed] [Google Scholar]
  19. Slott P. A., Liu M. H., Tavoloni N. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology. 1990 Aug;99(2):466–477. doi: 10.1016/0016-5085(90)91030-a. [DOI] [PubMed] [Google Scholar]
  20. Sreedharan S. P., Kodama K. T., Peterson K. E., Goetzl E. J. Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem. 1989 Jan 15;264(2):949–952. [PubMed] [Google Scholar]
  21. Tracy T. F., Jr, Goerke M. E., Bailey P. V., Sotelo-Avila C., Weber T. R. Growth-related gene expression in early cholestatic liver injury. Surgery. 1993 Sep;114(3):532–537. [PubMed] [Google Scholar]
  22. Tsuzaki S., Moses A. C. Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-I in FRTL5 cells. Endocrinology. 1990 Jun;126(6):3131–3138. doi: 10.1210/endo-126-6-3131. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES